List of Tables
Table 1. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pirfenidone
Table 3. Key Players of Nintedanib
Table 4. Key Players of Other
Table 5. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Region (2020-2025)
Table 9. Global Idiopathic Pulmonary Fibrosis Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Region (2026-2031)
Table 11. Idiopathic Pulmonary Fibrosis Disease Treatment Market Trends
Table 12. Idiopathic Pulmonary Fibrosis Disease Treatment Market Drivers
Table 13. Idiopathic Pulmonary Fibrosis Disease Treatment Market Challenges
Table 14. Idiopathic Pulmonary Fibrosis Disease Treatment Market Restraints
Table 15. Global Idiopathic Pulmonary Fibrosis Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Players (2020-2025)
Table 17. Global Top Idiopathic Pulmonary Fibrosis Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment as of 2024)
Table 18. Ranking of Global Top Idiopathic Pulmonary Fibrosis Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Idiopathic Pulmonary Fibrosis Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Idiopathic Pulmonary Fibrosis Disease Treatment, Headquarters and Area Served
Table 21. Global Key Players of Idiopathic Pulmonary Fibrosis Disease Treatment, Product and Application
Table 22. Global Key Players of Idiopathic Pulmonary Fibrosis Disease Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Idiopathic Pulmonary Fibrosis Disease Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Idiopathic Pulmonary Fibrosis Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Idiopathic Pulmonary Fibrosis Disease Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Idiopathic Pulmonary Fibrosis Disease Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Idiopathic Pulmonary Fibrosis Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Idiopathic Pulmonary Fibrosis Disease Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Boehringer Ingelheim Company Details
Table 48. Boehringer Ingelheim Business Overview
Table 49. Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 50. Boehringer Ingelheim Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 51. Boehringer Ingelheim Recent Development
Table 52. Merck and Co., Inc. Company Details
Table 53. Merck and Co., Inc. Business Overview
Table 54. Merck and Co., Inc. Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 55. Merck and Co., Inc. Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 56. Merck and Co., Inc. Recent Development
Table 57. ArkBio Company Details
Table 58. ArkBio Business Overview
Table 59. ArkBio Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 60. ArkBio Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 61. ArkBio Recent Development
Table 62. Zelgen Company Details
Table 63. Zelgen Business Overview
Table 64. Zelgen Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 65. Zelgen Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 66. Zelgen Recent Development
Table 67. Blade Therapeutics Company Details
Table 68. Blade Therapeutics Business Overview
Table 69. Blade Therapeutics Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 70. Blade Therapeutics Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 71. Blade Therapeutics Recent Development
Table 72. Regend Therapeutics (Cayman) Ltd. Company Details
Table 73. Regend Therapeutics (Cayman) Ltd. Business Overview
Table 74. Regend Therapeutics (Cayman) Ltd. Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 75. Regend Therapeutics (Cayman) Ltd. Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 76. Regend Therapeutics (Cayman) Ltd. Recent Development
Table 77. Insilico Medicine Company Details
Table 78. Insilico Medicine Business Overview
Table 79. Insilico Medicine Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 80. Insilico Medicine Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 81. Insilico Medicine Recent Development
Table 82. Vicore Pharma Company Details
Table 83. Vicore Pharma Business Overview
Table 84. Vicore Pharma Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 85. Vicore Pharma Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 86. Vicore Pharma Recent Development
Table 87. Heilongjiang Zbd Pharmaceutical Company Details
Table 88. Heilongjiang Zbd Pharmaceutical Business Overview
Table 89. Heilongjiang Zbd Pharmaceutical Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 90. Heilongjiang Zbd Pharmaceutical Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 91. Heilongjiang Zbd Pharmaceutical Recent Development
Table 92. Indaco Company Details
Table 93. Indaco Business Overview
Table 94. Indaco Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 95. Indaco Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 96. Indaco Recent Development
Table 97. InterMune, Inc. Company Details
Table 98. InterMune, Inc. Business Overview
Table 99. InterMune, Inc. Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 100. InterMune, Inc. Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 101. InterMune, Inc. Recent Development
Table 102. Bristol Myers Squibb Company Details
Table 103. Bristol Myers Squibb Business Overview
Table 104. Bristol Myers Squibb Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 105. Bristol Myers Squibb Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 106. Bristol Myers Squibb Recent Development
Table 107. SHIONOGI & CO., Ltd. Company Details
Table 108. SHIONOGI & CO., Ltd. Business Overview
Table 109. SHIONOGI & CO., Ltd. Idiopathic Pulmonary Fibrosis Disease Treatment Product
Table 110. SHIONOGI & CO., Ltd. Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025) & (US$ Million)
Table 111. SHIONOGI & CO., Ltd. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Idiopathic Pulmonary Fibrosis Disease Treatment Picture
Figure 2. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Pirfenidone Features
Figure 5. Nintedanib Features
Figure 6. Other Features
Figure 7. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Graduate School Case Studies
Figure 11. Others Case Studies
Figure 12. Idiopathic Pulmonary Fibrosis Disease Treatment Report Years Considered
Figure 13. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Players in 2024
Figure 17. Global Top Idiopathic Pulmonary Fibrosis Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Pulmonary Fibrosis Disease Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Idiopathic Pulmonary Fibrosis Disease Treatment Revenue in 2024
Figure 19. North America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Country (2020-2031)
Figure 21. United States Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Country (2020-2031)
Figure 25. Germany Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Region (2020-2031)
Figure 33. China Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Idiopathic Pulmonary Fibrosis Disease Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Idiopathic Pulmonary Fibrosis Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 49. Merck and Co., Inc. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 50. ArkBio Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 51. Zelgen Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 52. Blade Therapeutics Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 53. Regend Therapeutics (Cayman) Ltd. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 54. Insilico Medicine Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 55. Vicore Pharma Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 56. Heilongjiang Zbd Pharmaceutical Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 57. Indaco Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 58. InterMune, Inc. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 59. Bristol Myers Squibb Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 60. SHIONOGI & CO., Ltd. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Disease Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
